HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
175850.0,229588,2135-01-09 07:00:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia:
   Presented to hospital with approximately one week of fatigue, anorexia,
   and weight loss. Noted to have initial WBC count of 138k with 84%
   blasts. Was treated initially with leukopheresis and has received total
   of 4 doses of hydroxyurea. Course has been complicated by tumor lysis
   syndrome and disseminated intravascular coagulation.
   - Continue Hydroxyurea 2500 mg [**Hospital1 **] for two additional doses and then
   readdress additional chemotherapy as per bone marrow transplant team
   recommendations
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML. Has received rasburicase. Currently has potassium
   of 3, uric acid of 2.5, phosphate of 11.5, and LDH 2700.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Maintain alkalemia with goal serum bicarb of 30 to 34
   - Maintain adequate urine output for renal protection
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   .
   #. Hypotension:
   Likely caused by hypovolemia as patient has been fluid responsive with
   small boluses on the BMT floor. Additional supporting evidence is that
   patient has low urine output, thirst, and visibly dry mucous membranes.
   Patient is without ECHO evidence of systolic dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia:
   Likely multifactorial with contributions from pneumonia, edema, and
   possible leukemic infiltrate. Patient with cough productive of thick
   yellow sputum at this time. Presented to the ICU on vancomycin and
   cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.7, PLT 11, Fibrinogen 181. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, though no evidence of bleeding at this point.
   - Monitor Q6H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Platelet transfusion now with post-transfusion PLT count
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: ICU for blood pressure monitoring peri-dialysis
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia:
   Presented to hospital with approximately one week of fatigue, anorexia,
   and weight loss. Noted to have initial WBC count of 138k with 84%
   blasts. Was treated initially with leukopheresis and has received total
   of 4 doses of hydroxyurea. Course has been complicated by tumor lysis
   syndrome and disseminated intravascular coagulation.
   - Continue Hydroxyurea 2500 mg [**Hospital1 **] for two additional doses and then
   readdress additional chemotherapy as per bone marrow transplant team
   recommendations
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML. Has received rasburicase. Currently has potassium
   of 3, uric acid of 2.5, phosphate of 11.5, and LDH 2700.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Maintain alkalemia with goal serum bicarb of 30 to 34
   - Maintain adequate urine output for renal protection
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   .
   #. Hypotension:
   Likely caused by hypovolemia as patient has been fluid responsive with
   small boluses on the BMT floor. Additional supporting evidence is that
   patient has low urine output, thirst, and visibly dry mucous membranes.
   Patient is without ECHO evidence of systolic dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia:
   Likely multifactorial with contributions from pneumonia, edema, and
   possible leukemic infiltrate. Patient with cough productive of thick
   yellow sputum at this time. Presented to the ICU on vancomycin and
   cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.7, PLT 11, Fibrinogen 181. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, though no evidence of bleeding at this point.
   - Monitor Q6H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Platelet transfusion now with post-transfusion PLT count
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: ICU for blood pressure monitoring peri-dialysis<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health progress in the ICU as follows:

The patient is an 80-year-old male with a diagnosis of acute myeloid leukemia (AML), presenting with fatigue, anorexia, and weight loss. He has received leukopheresis and hydroxyurea treatment, but his course has been complicated by tumor lysis syndrome and disseminated intravascular coagulation (DIC).

The patient's vital signs are stable, with a temperature of 37.2°C, heart rate of 72 bpm, and blood pressure of 104/52 mmHg. He is receiving respiratory support with oxygen delivery and has a SpO2 of 100%. His laboratory results show worsening tumor lysis syndrome, with potassium levels of 3, uric acid levels of 2.5, and phosphate levels of 11.5.

The patient is at risk for several potential medical complications, including:

1. Renal failure: The patient's creatinine levels are elevated, and he is at risk for acute renal failure due to his underlying leukemia and tumor lysis syndrome.
2. Bleeding complications: The patient has DIC, which may lead to bleeding complications, particularly with his rapidly falling platelet count.
3. Hypoxia: The patient's pneumonia may worsen, leading to hypoxia, and his edema may increase, making it difficult to manage his fluid status.
4. Infection: The patient's pneumonia and leukopenia make him susceptible to secondary infections.
5. Cardiovascular instability: The patient's hypotension may worsen, and he may require vasopressors to maintain his blood pressure.

The patient's plan of care includes:

1. Continuation of hydroxyurea therapy
2. Aggressive repletion of potassium and phosphorus levels
3. Maintenance of alkalemia and adequate urine output
4. Monitoring of the patient's platelet count and INR
5. Treatment of DIC with platelet transfusions and cryoprecipitate as needed
6. Antibiotic therapy for community-acquired pathogens
7. Close monitoring of the patient's blood pressure and fluid status
8. Consideration of dialysis for acute renal failure

Overall, the patient requires close monitoring and management of his complex medical condition to prevent potential complications and optimize his outcomes."
175850.0,229588,2135-01-09 08:21:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems: overall this am feels well, no CP, SOB, abd pain,
   N/V.  still feels that hands are swollen
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
   10
        [image002.jpg]
   N44, Band2, lymph8, blast42
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 6 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team
   recommendations
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML but improved since dialysis. Has received
   rasburicase. Currently has potassium of 4.2, uric acid of 1.0,
   phosphate of 5.2, and LDH 2565.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Maintain alkalemia with goal serum bicarb of 30 to 34: give bicarb
   now for bicarb of 29
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   .
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor. Additional supporting
   evidence is that patient has low urine output, thirst, and visibly dry
   mucous membranes. Patient is without ECHO evidence of systolic
   dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time. Presented to the ICU on vancomycin
   and cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H (D1:[**1-8**]) for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.5, PLT 31, Fibrinogen 280. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, and has been transfused X1 without evidence of
   bleeding
   - Monitor Q6H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: ICU for blood pressure monitoring peri-dialysis
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems: overall this am feels well, no CP, SOB, abd pain,
   N/V.  still feels that hands are swollen
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
   10
        [image002.jpg]
   N44, Band2, lymph8, blast42
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 6 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team
   recommendations
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML but improved since dialysis. Has received
   rasburicase. Currently has potassium of 4.2, uric acid of 1.0,
   phosphate of 5.2, and LDH 2565.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Maintain alkalemia with goal serum bicarb of 30 to 34: give bicarb
   now for bicarb of 29
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   .
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor. Additional supporting
   evidence is that patient has low urine output, thirst, and visibly dry
   mucous membranes. Patient is without ECHO evidence of systolic
   dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time. Presented to the ICU on vancomycin
   and cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H (D1:[**1-8**]) for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.5, PLT 31, Fibrinogen 280. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, and has been transfused X1 without evidence of
   bleeding
   - Monitor Q6H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: ICU for blood pressure monitoring peri-dialysis<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with a diagnosis of acute myeloid leukemia (AML) who has been admitted to the ICU for management of various complications. The patient's current condition is as follows:

* Respiratory status: The patient is receiving oxygen therapy and has a SpO2 of 100%. His ABG results show a pH of 7.29, which is slightly acidic.
* Cardiovascular status: The patient's blood pressure is 104/52 mmHg, which is slightly low. His heart rhythm is sinus rhythm, and his cardiac output is normal.
* Renal status: The patient has acute renal failure, as evidenced by his creatinine level of 1.5 mg/dL and his blood urea nitrogen (BUN) level of 27 mg/dL. He is receiving dialysis and has a potassium level of 4.2 mEq/L.
* Hematological status: The patient has disseminated intravascular coagulation (DIC), as evidenced by his FDP level of 80-160, INR of 1.5, and platelet count of 31.
* Infectious status: The patient has a cough productive of thick yellow sputum and is receiving antibiotics for community-acquired pathogens.
* Nutritional status: The patient is receiving a regular renal diet.

Potential medical complications that may arise include:

1. Sepsis: The patient's infection and underlying immunosuppression make him susceptible to sepsis.
2. Bleeding: The patient's DIC and low platelet count increase his risk of bleeding.
3. Renal failure: The patient's acute renal failure may progress to chronic kidney disease if not managed properly.
4. Respiratory failure: The patient's underlying lung disease and respiratory compromise increase his risk of respiratory failure.
5. Cardiovascular complications: The patient's underlying cardiovascular disease and hypotension increase his risk of cardiovascular complications, such as myocardial infarction or cardiac arrest.
6. Tumor lysis syndrome: The patient's underlying leukemia and chemotherapy may cause tumor lysis syndrome, which can lead to acute kidney injury, hyperkalemia, and cardiac arrhythmias.
7. Infection: The patient's immunosuppression and underlying disease increase his risk of infection, which can be life-threatening.

The patient's current treatment plan includes:

1. Chemotherapy for his AML
2. Dialysis for his acute renal failure
3. Antibiotics for his pneumonia
4. Supportive care for his respiratory and cardiovascular compromise
5. Management of his DIC and bleeding risk
6. Nutritional support with a regular renal diet

The patient's family has been informed of his condition and has provided consent for his treatment. The patient's daughter has been identified as his primary contact, and the healthcare provider has been informed of his wishes regarding end-of-life care."
175850.0,229588,2135-01-09 08:21:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems: overall this am feels well, no CP, SOB, abd pain,
   N/V.  still feels that hands are swollen
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
   10
        [image002.jpg]
   N44, Band2, lymph8, blast42
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team
   recommendations- will likely have 2 additional doses ordered beyond the
   single dose already ordered for today and then possibly Gemcitabine
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML but improved since dialysis. Has received
   rasburicase. Currently has potassium of 4.2, uric acid of 1.0,
   phosphate of 5.2, and LDH 2565.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Plan was serum bicarb of 20-34 in order to excrete UA, but as UA
   decreased, ? if need to still give bicarb.  Will ask renal.
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor. Additional supporting
   evidence is that patient has low urine output, thirst, and visibly dry
   mucous membranes. Patient is without ECHO evidence of systolic
   dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time. Presented to the ICU on vancomycin
   and cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H (D1:[**1-8**]) for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.5, PLT 31, Fibrinogen 280. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, and has been transfused X1 without evidence of
   bleeding
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -PPI
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: c/o if patient can come off of CVVH, will discuss with
   renal
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 PHERESIS CATHETER - START [**2135-1-8**] 01:30 PM
   -started on PPI
   -platelets 11 to 53 after platelet transfusion
   -mild repletion of K and Mg, then calcium
   -pm labs for DIC improving, tumor lysis labs stable except for LDH
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Cefipime - [**2135-1-9**] 03:28 AM
   Infusions:
   Calcium Gluconate (CRRT) - 1.4 grams/hour
   KCl (CRRT) - 3 mEq./hour
   Other ICU medications:
   Other medications:
   20 gm Calcium Gluconate/ 500 mL D5W 5. Allopurinol 6. Aluminum
   Hydroxide Suspension
   7. Artificial Tears Preserv. Free 8. Calcium Gluconate 9. CefePIME 10.
   Heparin Flush (1000 units/mL)
   11. Heparin Flush (10 units/ml) 12. Heparin Flush (5000 Units/mL) 13.
   Hydroxyurea 14. Levofloxacin
   15. Magnesium Sulfate 16. Ondansetron 17. Pantoprazole 18. Pneumococcal
   Vac Polyvalent 19. Potassium Chloride 10 mEq / 100 mL SW (CRRT Only)
   20. Potassium Chloride 21. Potassium Chloride (Powder) 22. Prismasate
   (B22 K4) 23. Prismasate (B32 K2)*
   24. Sodium Chloride 0.9% Flush 25. Sodium CITRATE 4% 26. Vancomycin
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems: overall this am feels well, no CP, SOB, abd pain,
   N/V.  still feels that hands are swollen
   Flowsheet Data as of  [**2135-1-9**] 06:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 72 (68 - 96) bpm
   BP: 104/52(64) {94/43(57) - 127/60(76)} mmHg
   RR: 18 (13 - 24) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    946 mL
                                                                    820 mL
   PO:
                                                                    600 mL
             TF:
   IVF:
                                                                    106 mL
                                                                    820 mL
   Blood products:
                                                                    240 mL
   Total out:
                                                                  2,096 mL
                                                                  1,036 mL
   Urine:
                                                                  1,990 mL
                                                                    530 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,150 mL
                                                                   -216 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 100%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   31 K/uL
   8.1 g/dL
   119 mg/dL
   1.5 mg/dL
   29 mEq/L
   4.2 mEq/L
   27 mg/dL
   103 mEq/L
   140 mEq/L
   24.0 %
   10
        [image002.jpg]
   N44, Band2, lymph8, blast42
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
   WBC
   21.9
   Hct
   25.9
   24.0
   Plt
   53
   31
   Cr
   1.4
   1.5
   Glucose
   153
   119
   Other labs: PT / PTT / INR:16.9/34.0/1.5, ALT / AST:152/126, Alk Phos /
   T Bili:116/0.6,, Fibrinogen:280 mg/dL, Albumin:2.7 g/dL, LDH:2565 IU/L,
   Ca++:7.9 mg/dL, Mg++:2.2 mg/dL, PO4:5.2 mg/dL
   Blood 12/19 pending
   Urine [**1-8**] pending
   Blood 12/19 pending
   Urine [**1-7**] negative
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   CT head [**1-8**] final read:
   1. No intracranial hemorrhage or edema.
   2. Prominence of the bifrontal CSF spaces, which may be due to
   parenchymal
   atrophy or chronic subdural hygromas.
   Assessment and Plan
 LEUKEMIA, ACUTE (ALL, AML, CANCER, MALIGNANT NEOPLASM)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
   80 yo male with no significant PMH, admitted with ALL, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team
   recommendations- will likely have 2 additional doses ordered beyond the
   single dose already ordered for today and then possibly Gemcitabine
   #. Tumor lysis syndrome:
   Laboratory evidence of tumor lysis has been worsening since initiation
   of treatment of AML but improved since dialysis. Has received
   rasburicase. Currently has potassium of 4.2, uric acid of 1.0,
   phosphate of 5.2, and LDH 2565.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Plan was serum bicarb of 20-34 in order to excrete UA, but as UA
   decreased, ? if need to still give bicarb.  Will ask renal.
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor. Additional supporting
   evidence is that patient has low urine output, thirst, and visibly dry
   mucous membranes. Patient is without ECHO evidence of systolic
   dysfunction.
   - Monitor closely during dialysis
   - Fluid bolus as needed to support blood pressure
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time. Presented to the ICU on vancomycin
   and cefepime; however, his pneumonia likely a product of community
   exposure, so he should receive antibiotics for community pathogens. As
   far as edema is concerned, patient is clinically dry and has had
   relative hypotension, so diuresis would be difficult in this setting.
   - Treat AML as above
   - Send sputum for gram stain and culture
   - Continue vancomycin and cefepime
   - Addition of levofloxacin 750 mg Q48H (D1:[**1-8**]) for coverage of
   community-acquired pathogens
   #. Disseminated intravascular coagulation:
   Currently with FDP 80-160, INR 1.5, PLT 31, Fibrinogen 280. Patient has
   not required cryoprecipitate or FFP at this point. Platelet count is
   rapidly falling, and has been transfused X1 without evidence of
   bleeding
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Trend HCT while platelets dropping and elevated INR
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   ICU Care
   Nutrition: Regular renal diet
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis line
   Prophylaxis:
   -PPI
   -DVT ppx with pneumoboots while concerned for DIC
   -Bowel regimen as needed for symptoms
   Communication:  [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: c/o if patient can come off of CVVH, will discuss with
   renal<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the patient's condition and potential medical complications:

**Patient's Condition:**

The patient is an 80-year-old male with a diagnosis of acute myeloid leukemia (AML) and is currently in the ICU due to complications from his treatment. He has a history of fatigue, anorexia, and weight loss, and was initially treated with leukopheresis and hydroxyurea. His course has been complicated by tumor lysis syndrome and disseminated intravascular coagulation (DIC).

**Potential Medical Complications:**

1. **Renal Failure:** The patient has acute renal failure, which is likely due to his underlying leukemia and treatment with hydroxyurea. He requires dialysis and is at risk for further deterioration of his renal function.
2. **Tumor Lysis Syndrome:** The patient has laboratory evidence of tumor lysis syndrome, which is a life-threatening condition that requires aggressive management with rasburicase, allopurinol, and aluminum hydroxide to control uric acid and phosphate levels.
3. **Disseminated Intravascular Coagulation (DIC):** The patient has DIC, which is a complication of his leukemia and treatment with hydroxyurea. He is at risk for bleeding and requires close monitoring of his coagulation parameters.
4. **Hypotension:** The patient has hypotension, which is likely due to hypovolemia and may require fluid boluses to support his blood pressure.
5. **Hypoxia:** The patient has hypoxia, which is likely due to pneumonia, edema, and possible leukemic infiltrate. He requires treatment with antibiotics and oxygen therapy.
6. **Leukopenia:** The patient has leukopenia, which is a complication of his chemotherapy and may increase his risk of infection.
7. **Fluid and Electrolyte Imbalance:** The patient has a fluid and electrolyte imbalance, which is likely due to his underlying leukemia and treatment with hydroxyurea. He requires close monitoring of his fluid and electrolyte levels to prevent further complications.
8. **Pneumonia:** The patient has pneumonia, which is likely due to community exposure and requires treatment with antibiotics.
9. **Edema:** The patient has edema, which is likely due to his underlying leukemia and treatment with hydroxyurea. He requires close monitoring of his fluid status to prevent further complications.

**Plan:**

The patient requires ongoing management of his AML, tumor lysis syndrome, DIC, and other complications. He requires close monitoring of his coagulation parameters, electrolyte levels, and fluid status. He also requires treatment with antibiotics and oxygen therapy for his pneumonia and hypoxia."
175850.0,229588,2135-01-10 06:58:00,Physician ,Physician Resident Progress Note,"TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH, recommended
   alkalinizing urine to bicarb of 28-34
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime, and levofloxacin (d1 [**1-8**])
 have
   confirmed levels but will need to follow-up vanc level at 6pm today.
   Will treat for 8 day course.
   #. Disseminated intravascular coagulation: Currently fibrinogen, coags,
   FDP stable.  Patient has not required cryoprecipitate or FFP at this
   point. Platelet count is rapidly falling, and has been transfused X1
   without evidence of bleeding but may need another transfusion today
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH, recommended
   alkalinizing urine to bicarb of 28-34
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime, and levofloxacin (d1 [**1-8**])
 have
   confirmed levels but will need to follow-up vanc level at 6pm today.
   Will treat for 8 day course.
   #. Disseminated intravascular coagulation: Currently fibrinogen, coags,
   FDP stable.  Patient has not required cryoprecipitate or FFP at this
   point. Platelet count is rapidly falling, and has been transfused X1
   without evidence of bleeding but may need another transfusion today
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male admitted with acute myeloid leukemia (AML) and is currently in the Intensive Care Unit (ICU). The patient's condition is complicated by tumor lysis syndrome, disseminated intravascular coagulation (DIC), and hypotension.

The patient's laboratory results show worsening tumor lysis syndrome, with laboratory evidence of tumor lysis syndrome and disseminated intravascular coagulation. The patient's potassium levels have decreased paradoxically due to renal wasting, and the nephrology team recommends aggressive repletion of potassium.

The patient's vital signs are stable, with a temperature of 36.6°C (97.9°F), heart rate of 76 beats per minute, and blood pressure of 118/58 mmHg. The patient's oxygen saturation is 92%, and he is receiving nasal cannula oxygen therapy.

The patient's physical examination is notable for the presence of bilateral crackles in the lungs, soft and non-tender abdomen, and no evidence of edema or bleeding.

The patient's medications include vancomycin, cefepime, and levofloxacin, which have been confirmed to be at therapeutic levels. The patient has also received rasburicase and aluminum hydroxide to control phosphate and uric acid levels.

The patient's plan of care includes readdressing additional chemotherapy as per the bone marrow transplant team, and may plan for decitabine next week. The patient will continue to receive alkalinization of urine, and will be monitored for tumor lysis syndrome, DIC, and hypotension.

Potential medical complications that can arise include:

1. Tumor lysis syndrome: Continued worsening of tumor lysis syndrome can lead to life-threatening complications such as cardiac arrhythmias, renal failure, and seizures.
2. Disseminated intravascular coagulation: Continued progression of DIC can lead to bleeding complications, including intracranial hemorrhage, and organ failure.
3. Hypotension: Failure to adequately manage hypotension can lead to organ hypoperfusion, including cardiac, renal, and cerebral hypoperfusion.
4. Pneumonia: Failure to treat pneumonia can lead to respiratory failure and sepsis.
5. Bleeding: Failure to adequately manage bleeding can lead to hemorrhagic shock and death.
6. Renal failure: Continued worsening of renal failure can lead to end-stage renal disease and the need for dialysis.

In conclusion, the patient's condition is complex and requires close monitoring and management to prevent potential medical complications. The patient's plan of care should be individualized to address his specific needs and goals."
175850.0,229588,2135-01-10 06:58:00,Physician ,Physician Resident Progress Note,"TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime, and levofloxacin (d1 [**1-8**])
 have
   confirmed levels but will need to follow-up vanc level at 6pm today.
   Will treat for 8 day course.
   #. Disseminated intravascular coagulation: Currently fibrinogen, coags,
   FDP stable.  Patient has not required cryoprecipitate or FFP at this
   point. Platelet count is rapidly falling, and has been transfused X1
   without evidence of bleeding but may need another transfusion today
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: rrr nl s1/s2 no mrg
   Pulm: cta b/l
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has received total of 4 doses of hydroxyurea. Course has been
   complicated by tumor lysis syndrome and disseminated intravascular
   coagulation.
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W
   - Maintain adequate urine output for renal protection: has been 30-130
   cc/hr
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid leves
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate. Patient with cough productive
   of thick yellow sputum at this time.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime, and levofloxacin (d1 [**1-8**])
 have
   confirmed levels but will need to follow-up vanc level at 6pm today.
   Will treat for 8 day course.
   #. Disseminated intravascular coagulation: Currently fibrinogen, coags,
   FDP stable.  Patient has not required cryoprecipitate or FFP at this
   point. Platelet count is rapidly falling, and has been transfused X1
   without evidence of bleeding but may need another transfusion today
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with a diagnosis of acute myeloid leukemia (AML). He was admitted to the hospital with fatigue, anorexia, and weight loss, and was initially treated with leukopheresis and hydroxyurea. His course has been complicated by tumor lysis syndrome, disseminated intravascular coagulation (DIC), and hypotension.

The patient's current vital signs are:

* Temperature: 36.6°C (97.9°F)
* Heart rate: 76 bpm (65-92 bpm)
* Blood pressure: 118/58 mmHg (73-126/93-96 mmHg)
* Respiratory rate: 20 breaths per minute (14-24 breaths per minute)
* Oxygen saturation: 92%

His laboratory results show:

* White blood cell count: 21.9 K/μL
* Hemoglobin: 7.4 g/dL
* Platelet count: 53 K/μL
* Creatinine: 1.4 mg/dL
* Glucose: 153 mg/dL
* Albumin: 2.4 g/dL
* Lactic acid: 1.2 mmol/L

The patient's physical examination reveals:

* General: NAD (no acute distress)
* Cardiovascular: RRR (regular rhythm and rate), no murmurs, no gallop
* Pulmonary: CTAB (clear to auscultation, bilateral)
* Abdominal: Soft, non-tender, non-distended
* Extremities: No edema, warm, non-tender

The patient's medical conditions include:

* Acute myeloid leukemia
* Tumor lysis syndrome
* Disseminated intravascular coagulation
* Hypotension
* Hypoxia
* Pneumonia
* Edema

The patient's plan includes:

* Readdressing additional chemotherapy as per the bone marrow transplant team
* Continuing hydroxyurea
* Treating tumor lysis syndrome with rasburicase
* Maintaining adequate urine output for renal protection
* Continuously monitoring laboratory results and adjusting treatment as necessary

Potential medical complications that can arise include:

* Tumor lysis syndrome: worsening of laboratory evidence, potential for renal failure, and cardiovascular instability
* Disseminated intravascular coagulation: worsening of coagulopathy, potential for bleeding, and cardiovascular instability
* Hypotension: worsening of hypovolemia, potential for cardiovascular instability, and organ dysfunction
* Hypoxia: worsening of respiratory failure, potential for respiratory arrest, and cardiovascular instability
* Pneumonia: worsening of respiratory failure, potential for respiratory arrest, and cardiovascular instability
* Edema: worsening of cardiac failure, potential for cardiac arrest, and respiratory failure

It is essential to closely monitor the patient's condition and adjust treatment as necessary to prevent these potential complications."
175850.0,229588,2135-01-10 06:58:00,Physician ,Physician Resident Progress Note,"TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH, recommended
   alkalinizing urine to bicarb of 28-34
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: RRR nl s1/s2 no mrg
   Pulm: CTAB
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has hydroxyurea. Course has been complicated by tumor lysis
   syndrome and disseminated intravascular coagulation.
   - continue decreased dose of hydroxyurea today and tomorrow
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W in order to prevent uric acid crystal
   accumulation
   - Maintain adequate urine output for renal protection
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid levels
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime (d1 [**1-7**]), and levofloxacin (d1 [**1-8**])
 have confirmed levels but will need to follow-up vanc level at 6pm
   today.  Will treat for 8 day course.
   #. Disseminated intravascular coagulation/Anemia: Currently fibrinogen,
   coags, FDP stable.  Patient has not required cryoprecipitate or FFP at
   this point.  Platelet count dropping but no signs of bleeding.
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am and recheck
   post-transfusion Hct
   - Feel that anemia is likely secondary to hydroxyurea administration,
   but will add on hapto to am labs to evaluate for hemolysis
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines: 20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: [**Hospital Unit Name 10**] Resident Progress Note
   Chief Complaint: Acute myeloid leukemia
   24 Hour Events:
   - Renal saw patient, said it is ok to stop CVVH, and will check lytes
   overnight to make sure he tolerates not being on CVVH, recommended
   alkalinizing urine to bicarb of 28-34
   - Given 1g IV Vanc, needs level checked 6pm [**1-10**], confirmed dose of
   other antibiotics
   - Had Hct of 21.8 this morning, given 1 unit PRBCs
   - BMT following, recommended decreased dose of hydroxyurea today
   (2500mg), can transfer out of MICU when stable, continue antibiotics,
   transfuse for Hct<25, plts <10 (or <20 if bleeding), check tumor lysis
   labs q8h
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-9**] 08:00 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 76 (65 - 92) bpm
   BP: 118/58(73) {92/45(59) - 126/93(96)} mmHg
   RR: 20 (14 - 24) insp/min
   SpO2: 92%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
             Total In:
                                                                  4,504 mL
                                                                    391 mL
   PO:
                                                                  1,800 mL
             TF:
   IVF:
                                                                  2,704 mL
                                                                    391 mL
   Blood products:
   Total out:
                                                                  2,899 mL
                                                                    880 mL
   Urine:
                                                                  2,215 mL
                                                                    880 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -489 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 92%
   ABG: ///29/
   Physical Examination
   Gen: NAD
   CV: RRR nl s1/s2 no mrg
   Pulm: CTAB
   Abd: +BS, soft NTND
   Ext: no edema, warm, NT
   Labs / Radiology
   17 K/uL
   7.4 g/dL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   ALT: 100
   AP: 100
   Tbili: 0.5
   Alb: 2.4
   AST: 61
   LDH: 1581
   Dbili:
   TProt:
   [**Doctor First Name 92**]:
   Lip:
   (past LDH 2565)
   Source: Line-right SC
   Other Hematology
   FDP: 10-40
   Fibrinogen: 286
   Blood 12/19 pending
   Urine [**1-8**] culture final no growth
   Blood 12/19 pending
   Blood 12/18 pending
   HCV VL, HBV VL [**1-7**] pending
   Assessment and Plan
   80 yo male with no significant PMH, admitted with AML, initial WBC 137
   with 88% blasts, uric acid of 22 on admission.
   #. Acute myeloid leukemia: Presented to hospital with approximately one
   week of fatigue, anorexia, and weight loss. Noted to have initial WBC
   count of 138k with 84% blasts. Was treated initially with leukopheresis
   and has hydroxyurea. Course has been complicated by tumor lysis
   syndrome and disseminated intravascular coagulation.
   - continue decreased dose of hydroxyurea today and tomorrow
   - readdress additional chemotherapy as per bone marrow transplant team,
   may plan for decitabine next week
   #. Tumor lysis syndrome: Laboratory evidence of tumor lysis has been
   worsening since initiation of treatment of AML but improved since
   dialysis. Has received rasburicase. Currently labs are stable after
   stopping CVVH.
   - Appreciate nephrology recs
   - Paradoxic decrease in potassium due to renal wasting and potassium
   should be aggressively repleted per nephrology recs
   - Will alkalinize urine per renal recs, currently giving 100cc/hr 150
   mEq Sodium Bicarb/1000ml D5W in order to prevent uric acid crystal
   accumulation
   - Maintain adequate urine output for renal protection
   - Continue Aluminum Hydroxide as well as allopurinol to control phos
   and uric acid levels
   #. Hypotension: Likely caused by hypovolemia as patient has been fluid
   responsive with small boluses on the BMT floor.  Patient is without
   ECHO evidence of systolic dysfunction.
   - Fluid bolus as needed to support blood pressure, did not require any
   fluid boluses overnight
   #. Hypoxia: Likely multifactorial with contributions from pneumonia,
   edema, and possible leukemic infiltrate.
   - Treat AML as above
   - Send sputum for gram stain and culture, may need to reorder
   - Continue vancomycin, cefepime (d1 [**1-7**]), and levofloxacin (d1 [**1-8**])
 have confirmed levels but will need to follow-up vanc level at 6pm
   today.  Will treat for 8 day course.
   #. Disseminated intravascular coagulation/Anemia: Currently fibrinogen,
   coags, FDP stable.  Patient has not required cryoprecipitate or FFP at
   this point.  Platelet count dropping but no signs of bleeding.
   - Monitor Q8H PTT, INR, FDP, fibrinogen, platelets
   - Treat fibrinogen < 100 with cryoprecipitate
   - Treat INR > 2.0 with FFP
   - Transfuse for platelets <10 if not bleeding, <20 if bleeding
   - Transfuse for Hct<25, will give 1 unit PRBCs this am and recheck
   post-transfusion Hct
   - Feel that anemia is likely secondary to hydroxyurea administration,
   but will add on hapto to am labs to evaluate for hemolysis
   ICU Care
   Nutrition: Regular renal diet
   Glycemic Control:
   Lines: 20 Gauge - [**2135-1-8**] 01:29 PM
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   Prophylaxis:
   DVT: PPI
   Stress ulcer: DVT ppx with pneumoboots while concerned for DIC
   VAP:
   Comments: Bowel regimen as needed for symptoms
   Communication:  Comments: [**First Name8 (NamePattern2) 1094**] [**Last Name (NamePattern1) 9968**] (daughter) [**Telephone/Fax (1) 9969**]; also is
   his HCP
   [**Name (NI) 129**] status: FULL, would not want long term life support
   Disposition: Likely can be called out to floor today (BMT service)<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with a chief complaint of acute myeloid leukemia (AML). He was admitted with an initial WBC count of 138k with 84% blasts and has been treated with leukopheresis and hydroxyurea. The course has been complicated by tumor lysis syndrome and disseminated intravascular coagulation (DIC).

The patient's current vital signs are:

* T-max: 36.6°C (97.9°F)
* T-current: 36.6°C (97.9°F)
* HR: 76 bpm (65-92 bpm)
* BP: 118/58 mmHg (73-126/93-96 mmHg)
* RR: 20 inspirations per minute (14-24 inspirations per minute)
* SpO2: 92%

The patient's physical examination is as follows:

* Gen: NAD (no abnormal findings)
* CV: RRR (regular rate and rhythm) with no murmurs
* Pulm: CTAB (clear to auscultation bilaterally)
* Abd: +BS (soft and tender to the touch)
* Ext: no edema, warm, and non-tender

The patient's laboratory results are as follows:

* WBC: 21.9
* Hct: 21.8%
* Plt: 53
* Cr: 1.4
* Glucose: 153
* Other labs: PT/PTT/INR: 15.0/35.0/1.3, ALT/AST: 100/61, Alk Phos/T Bili: 100/0.5, Differential-Neuts: 44.0%, Band: 2.0%, Lymph: 8.0%, Mono: 3.0%, Eos: 0.0%, Fibrinogen: 286 mg/dL, Lactic Acid: 1.2 mmol/L, Albumin: 2.4 g/dL, LDH: 1581 IU/L, Ca++: 7.5 mg/dL, Mg++: 1.6 mg/dL, PO4: 4.7 mg/dL

The patient's medical plan includes:

* Continuing decreased dose of hydroxyurea today and tomorrow
* Readdressing additional chemotherapy as per bone marrow transplant team, possibly planning for decitabine next week
* Alkalinizing urine per renal recommendations
* Maintaining adequate urine output for renal protection
* Continuing Aluminum Hydroxide and allopurinol to control phosphate and uric acid levels
* Monitoring Q8H PTT, INR, FDP, fibrinogen, platelets
* Treating fibrinogen < 100 with cryoprecipitate
* Treating INR > 2.0 with FFP
* Transfusing for platelets <10 if not bleeding, <20 if bleeding
* Transfusing for Hct < 25
* Evaluating for hemolysis with hapto in am labs

Potential medical complications that can arise include:

* Tumor lysis syndrome worsening
* Disseminated intravascular coagulation (DIC) worsening
* Hypotension due to hypovolemia
* Hypoxia due to pneumonia, edema, and possible leukemic infiltrate
* Anemia due to hydroxyurea administration
* Bleeding due to thrombocytopenia
* Renal failure due to inadequate urine output

It is essential to closely monitor the patient's condition and adjust the treatment plan accordingly to prevent or manage these potential complications."
175850.0,229588,2135-01-10 10:28:00,Physician ,Physician Attending Progress Note,"Chief Complaint: DIC, TLS, arf
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   80 M with newly diagnosed AML complicated by TLS and DIC, transferred
   to the ICU for hemodialysis for hyperphosphatemia.
   24 Hour Events:
   CVVH stopped yesterday
   transfused 1 unit prbc this morning for hct 21
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-10**] 08:38 AM
   Infusions:
   Other ICU medications:
   Other medications:
   per [**Month (only) **] (reviewed)
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 10:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.3
C (97.3
   HR: 73 (65 - 92) bpm
   BP: 104/48(63) {92/45(59) - 120/93(97)} mmHg
   RR: 18 (16 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
           Total In:
                                                                  4,504 mL
                                                                  1,302 mL
   PO:
                                                                  1,800 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  2,704 mL
                                                                    527 mL
   Blood products:
   295 mL
   Total out:
                                                                  2,899 mL
                                                                  1,620 mL
   Urine:
                                                                  2,215 mL
                                                                  1,620 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -318 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///29/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: No(t) Endotracheal tube
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Warm
   Neurologic: Attentive and appropriate
   Labs / Radiology
   7.4 g/dL
   17 K/uL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   Microbiology: [**1-7**] and 19 bl pending
   urine [**1-8**]-neg
   hcv hbv pending
   Assessment and Plan
   80 M with newly diagnosed AML complicated by TLS and DIC, transferred
   to the ICU for hemodialysis for hyperphosphatemia.
   Primary issues include:
   # Tumor Lysis Syndrome
   - labs much improved
   -CVVH stopped yesterday
   -continue alkalinization of urine, follow uric acid level
   - q8 hr tumor lysis labs
   --monitor urine outpt and renal fx closely
   # AML
   -Receiving hydroxyurea,
   -BMT regarding plan for additional chemotherapy
   # DIC:
   --follow serial labs
   --transfuse for platelets <20K,
         INR > 2, ffp
        fibrinogen <100, cryoprecipitate
   --Given decline in hct, suspect hydroxyurea effect
   --Monitor for hemolysis
   # Hypoxemia: ? secondary to pneumonia v. edema v. leukemic effect,
   improved
   - continue day [**4-28**] empiric vanc/cefepime/l day [**3-28**] levofloxacin, given
   functional neurtopenia
   --follow pending cx data
    Remainder as per resident note
   ICU Care
   Nutrition: renal diet
   Glycemic Control:
   Lines:
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   20 Gauge - [**2135-1-10**] 08:43 AM
   Prophylaxis:
   DVT:
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition : d/w bmt regarding floor transfer
   Total time spent: 35 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: DIC, TLS, arf
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   80 M with newly diagnosed AML complicated by TLS and DIC, transferred
   to the ICU for hemodialysis for hyperphosphatemia.
   24 Hour Events:
   CVVH stopped yesterday
   transfused 1 unit prbc this morning for hct 21
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-10**] 08:38 AM
   Infusions:
   Other ICU medications:
   Other medications:
   per [**Month (only) **] (reviewed)
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 10:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.3
C (97.3
   HR: 73 (65 - 92) bpm
   BP: 104/48(63) {92/45(59) - 120/93(97)} mmHg
   RR: 18 (16 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
           Total In:
                                                                  4,504 mL
                                                                  1,302 mL
   PO:
                                                                  1,800 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  2,704 mL
                                                                    527 mL
   Blood products:
   295 mL
   Total out:
                                                                  2,899 mL
                                                                  1,620 mL
   Urine:
                                                                  2,215 mL
                                                                  1,620 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -318 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///29/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: No(t) Endotracheal tube
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Warm
   Neurologic: Attentive and appropriate
   Labs / Radiology
   7.4 g/dL
   17 K/uL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   Microbiology: [**1-7**] and 19 bl pending
   urine [**1-8**]-neg
   hcv hbv pending
   Assessment and Plan
   80 M with newly diagnosed AML complicated by TLS and DIC, transferred
   to the ICU for hemodialysis for hyperphosphatemia.
   Primary issues include:
   # Tumor Lysis Syndrome
   - labs much improved
   -CVVH stopped yesterday
   -continue alkalinization of urine, follow uric acid level
   - q8 hr tumor lysis labs
   --monitor urine outpt and renal fx closely
   # AML
   -Receiving hydroxyurea,
   -BMT regarding plan for additional chemotherapy
   # DIC:
   --follow serial labs
   --transfuse for platelets <20K,
         INR > 2, ffp
        fibrinogen <100, cryoprecipitate
   --Given decline in hct, suspect hydroxyurea effect
   --Monitor for hemolysis
   # Hypoxemia: ? secondary to pneumonia v. edema v. leukemic effect,
   improved
   - continue day [**4-28**] empiric vanc/cefepime/l day [**3-28**] levofloxacin, given
   functional neurtopenia
   --follow pending cx data
    Remainder as per resident note
   ICU Care
   Nutrition: renal diet
   Glycemic Control:
   Lines:
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   20 Gauge - [**2135-1-10**] 08:43 AM
   Prophylaxis:
   DVT:
   Stress ulcer: ppi
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition : d/w bmt regarding floor transfer
   Total time spent: 35 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 80-year-old male with newly diagnosed Acute Myeloid Leukemia (AML) complicated by Tumor Lysis Syndrome (TLS) and Disseminated Intravascular Coagulation (DIC). He was transferred to the Intensive Care Unit (ICU) for hemodialysis due to hyperphosphatemia. The patient's primary issues include TLS, AML, and DIC. His labs show significant improvement, with a platelet count of 53 and a hemoglobin level of 7.4 g/dL. He is receiving hydroxyurea for AML and transfusions for platelets and coagulopathy. The patient is also receiving empiric antibiotics for suspected pneumonia.

Potential Medical Complications:

1. Tumor Lysis Syndrome (TLS): The patient's labs show improvement, but it is crucial to continue monitoring his uric acid levels and urine output to prevent further complications.
2. Disseminated Intravascular Coagulation (DIC): The patient's coagulopathy is being managed with transfusions, but it is essential to monitor his platelet count and INR to prevent bleeding and thrombotic complications.
3. Hypoxemia: The patient's hypoxemia may be secondary to pneumonia, edema, or leukemic effect. It is crucial to follow pending CXR data and continue empiric antibiotics to prevent further complications.
4. Renal Failure: The patient's hyperphosphatemia is being managed with hemodialysis, but it is essential to monitor his renal function closely to prevent further decline.
5. Infection: The patient's immunocompromised state makes him susceptible to infection. It is crucial to monitor his vital signs and lab results closely for signs of infection.
6. Bleeding: The patient's coagulopathy makes him at risk for bleeding. It is essential to monitor his platelet count and INR closely to prevent bleeding complications.
7. Organ Failure: The patient's underlying AML and DIC make him at risk for organ failure, including cardiac, respiratory, and renal failure. It is crucial to monitor his vital signs and lab results closely for signs of organ failure."
175850.0,229588,2135-01-10 10:28:00,Physician ,Physician Attending Progress Note,"Chief Complaint: DIC, tumor lysis, arf
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   CVVH stopped yesterday
   transfused 1 unit prbc this morning for hct 21
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-10**] 08:38 AM
   Infusions:
   Other ICU medications:
   Other medications:
   per [**Month (only) **] (reviewed)
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 10:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.3
C (97.3
   HR: 73 (65 - 92) bpm
   BP: 104/48(63) {92/45(59) - 120/93(97)} mmHg
   RR: 18 (16 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
           Total In:
                                                                  4,504 mL
                                                                  1,302 mL
   PO:
                                                                  1,800 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  2,704 mL
                                                                    527 mL
   Blood products:
   295 mL
   Total out:
                                                                  2,899 mL
                                                                  1,620 mL
   Urine:
                                                                  2,215 mL
                                                                  1,620 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -318 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///29/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: No(t) Endotracheal tube
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Musculoskeletal: No(t) Muscle wasting, No(t) Unable to stand
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, No(t) Sedated, Tone: Not assessed
   Labs / Radiology
   7.4 g/dL
   17 K/uL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   Microbiology: [**1-7**] and 19 bl pending
   urine [**1-8**]-neg
   hcv hbv pending
   Assessment and Plan
   # Tumor Lysis Syndrome
   - labs much improved and P04 down post-HD
   --CVVH stopped yesterday
   -continue alkalinization of urine given following uric acid,  follow
   uric acid level
   - follow q8 hr tumor lysis labs
   --Follow urine outpt and renal fx closely
   # AML
   -Receiving hydroxyurea,
   -BMT regarding plan for further chemotherapy
   # DIC: serial labs
   --transfuse for platelets <20K
   --if INR > 2, ffp
   --if fibrinogen <100, will transfuse cryoprecipitate
   --Given falling hct as well, suspect hydroxyurea effect
   --Monitor for hemolysis, check habtoglobin
   # Hypoxemia: ? secondary to pneumonia v. edema v. leukemic effect
   - continue day [**4-28**] empiric vanc/cefepime/l day [**3-28**] levofloxacin, given
   functional neurtopenia
   --follow pending cx data
    # Hypotension
   - resolved, likely hypovolemic, fluids as needed
   ICU Care
   Nutrition: renal diet
   Glycemic Control:
   Lines:
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   20 Gauge - [**2135-1-10**] 08:43 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition : d/w bmt regarding floor transfer
   Total time spent: 35 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: DIC, tumor lysis, arf
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   CVVH stopped yesterday
   transfused 1 unit prbc this morning for hct 21
   Allergies:
   Penicillins
   angioedema;
   Codeine
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2135-1-9**] 04:45 PM
   Cefipime - [**2135-1-10**] 08:38 AM
   Infusions:
   Other ICU medications:
   Other medications:
   per [**Month (only) **] (reviewed)
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2135-1-10**] 10:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.3
C (97.3
   HR: 73 (65 - 92) bpm
   BP: 104/48(63) {92/45(59) - 120/93(97)} mmHg
   RR: 18 (16 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 84.2 kg (admission): 80.8 kg
           Total In:
                                                                  4,504 mL
                                                                  1,302 mL
   PO:
                                                                  1,800 mL
                                                                    480 mL
   TF:
   IVF:
                                                                  2,704 mL
                                                                    527 mL
   Blood products:
   295 mL
   Total out:
                                                                  2,899 mL
                                                                  1,620 mL
   Urine:
                                                                  2,215 mL
                                                                  1,620 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,605 mL
                                                                   -318 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///29/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: No(t) Endotracheal tube
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Musculoskeletal: No(t) Muscle wasting, No(t) Unable to stand
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, No(t) Sedated, Tone: Not assessed
   Labs / Radiology
   7.4 g/dL
   17 K/uL
   114 mg/dL
   1.8 mg/dL
   29 mEq/L
   3.6 mEq/L
   35 mg/dL
   105 mEq/L
   140 mEq/L
   21.8 %
   2.4 K/uL
        [image002.jpg]
                            [**2135-1-8**]  06:36 PM
                            [**2135-1-9**]  04:10 AM
                            [**2135-1-9**]  09:50 AM
                            [**2135-1-9**]  03:34 PM
                            [**2135-1-9**]  09:53 PM
                            [**2135-1-10**]  04:21 AM
   WBC
   21.9
   10.0
   7.1
   5.1
   3.1
   2.4
   Hct
   25.9
   24.0
   25.1
   25.2
   23.0
   21.8
   Plt
   53
   31
   20
   21
   18
   17
   Cr
   1.4
   1.5
   1.4
   1.7
   1.8
   Glucose
   153
   119
   161
   153
   154
   114
   Other labs: PT / PTT / INR:15.0/35.0/1.3, ALT / AST:100/61, Alk Phos /
   T Bili:100/0.5, Differential-Neuts:44.0 %, Band:2.0 %, Lymph:8.0 %,
   Mono:3.0 %, Eos:0.0 %, Fibrinogen:286 mg/dL, Lactic Acid:1.2 mmol/L,
   Albumin:2.4 g/dL, LDH:1581 IU/L, Ca++:7.5 mg/dL, Mg++:1.6 mg/dL,
   PO4:4.7 mg/dL
   Microbiology: [**1-7**] and 19 bl pending
   urine [**1-8**]-neg
   hcv hbv pending
   Assessment and Plan
   # Tumor Lysis Syndrome
   - labs much improved and P04 down post-HD
   --CVVH stopped yesterday
   -continue alkalinization of urine given following uric acid,  follow
   uric acid level
   - follow q8 hr tumor lysis labs
   --Follow urine outpt and renal fx closely
   # AML
   -Receiving hydroxyurea,
   -BMT regarding plan for further chemotherapy
   # DIC: serial labs
   --transfuse for platelets <20K
   --if INR > 2, ffp
   --if fibrinogen <100, will transfuse cryoprecipitate
   --Given falling hct as well, suspect hydroxyurea effect
   --Monitor for hemolysis, check habtoglobin
   # Hypoxemia: ? secondary to pneumonia v. edema v. leukemic effect
   - continue day [**4-28**] empiric vanc/cefepime/l day [**3-28**] levofloxacin, given
   functional neurtopenia
   --follow pending cx data
    # Hypotension
   - resolved, likely hypovolemic, fluids as needed
   ICU Care
   Nutrition: renal diet
   Glycemic Control:
   Lines:
   Pheresis Catheter - [**2135-1-8**] 01:30 PM
   20 Gauge - [**2135-1-10**] 08:43 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition : d/w bmt regarding floor transfer
   Total time spent: 35 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 24-hour-old ICU admission with a chief complaint of Disseminated Intravascular Coagulation (DIC), tumor lysis syndrome, and acute renal failure (ARF). The patient is receiving treatment for acute myeloid leukemia (AML) and has been transfused with one unit of packed red blood cells for a hemoglobin level of 21 g/dL. The patient's vital signs are stable, with a temperature of 36.3°C, heart rate of 73 bpm, and blood pressure of 104/48 mmHg. The patient's respiratory support includes nasal cannula oxygen delivery, with an SpO2 of 97%. The patient's laboratory results show improved tumor lysis syndrome lab values, with a phosphorus level of 1.8 mg/dL, and a white blood cell count of 21.9 K/uL.

Potential Medical Complications:

1. Tumor Lysis Syndrome: The patient's tumor lysis syndrome lab values are improving, but the patient is still at risk for hyperkalemia, hyperphosphatemia, and hypocalcemia. Close monitoring of these lab values is essential to prevent complications.
2. DIC: The patient's DIC lab values are stable, but the patient is at risk for bleeding complications due to low platelet counts. Transfusion of platelets and cryoprecipitate may be necessary to prevent bleeding.
3. ARF: The patient's ARF is being managed with continuous venovenous hemofiltration (CVVH), which has been stopped. The patient's creatinine level is 1.4 mg/dL, and the patient's urine output is 2,215 mL over the past 24 hours.
4. Hypoxemia: The patient's hypoxemia is being managed with nasal cannula oxygen delivery, but the patient's SpO2 is only 97%. The patient's hypoxemia may be secondary to pneumonia, edema, or leukemic effect, and further evaluation is necessary to determine the cause.
5. Hypotension: The patient's hypotension has resolved, but the patient is at risk for hypovolemic shock due to ongoing fluid losses. Close monitoring of the patient's blood pressure and fluid status is essential to prevent complications.
6. Infection: The patient is at risk for infection due to immunosuppression and indwelling lines. Close monitoring of the patient's temperature and laboratory values is essential to detect any signs of infection.
7. Bleeding: The patient is at risk for bleeding complications due to low platelet counts and DIC. Close monitoring of the patient's bleeding status and lab values is essential to prevent complications.

Overall, the patient's condition is stable, but close monitoring is necessary to prevent complications and ensure optimal treatment."
